Kura Oncology (KURA) Net Equity Issued and Repurchased (2015 - 2026)
Kura Oncology's Net Equity Issued and Repurchased came in at $1.5 million for Q2 2026, up 191.1% from $515,000 a year earlier.
Powered by 
Analysis
Kura Oncology (KURA) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kura Oncology reported Net Equity Issued and Repurchased of $2.7 million, down 26.3% year-over-year; for FY2025, it was $1.79 million, down 79.2% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -67.0% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $8.6 million in FY2024 (+613.4%), $1.21 million in FY2023 (-72.7%), $4.42 million in FY2022 (-0.2%) and $4.43 million in FY2021 (-99.0%).
- The Q2 2026 figure represents the highest quarterly Net Equity Issued and Repurchased since Q3 2024.
- Year-over-year, Net Equity Issued and Repurchased increased in three of the last six quarters, with growth averaging 3.2%.
- The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q2 2022 (growth of 389.7%), and the weakest in Q4 2021 (a decline of 99.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Kura Oncology | 947.36 Mn | 947.36 Mn | 20.63 Mn | 1.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Mn |
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 1.14 Mn |
| Jun 30, 2025 | 515,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Dec 31, 2024 | 807,000.00 |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 3.04 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Dec 31, 2023 | 691,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Dec 31, 2022 | 567,000.00 |
| Sep 30, 2022 | 880,000.00 |
| Jun 30, 2022 | 2.67 Mn |
| Mar 31, 2022 | 303,000.00 |
| Dec 31, 2021 | 794,000.00 |
| Sep 30, 2021 | 2.26 Mn |
| Jun 30, 2021 | 545,000.00 |
| Mar 31, 2021 | 829,000.00 |
| Dec 31, 2020 | 324.34 Mn |
API Access
Kura Oncology Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();